Abstract:The immune response holds a pivotal role in cardiovascular disease development. As multifunctional cells of the innate immune system, macrophages play an essential role in initial inflammatory response that occurs following cardiovascular injury, thereby inducing subsequent damage while also facilitating recovery. Meanwhile, the diverse phenotypes and phenotypic alterations of macrophages strongly associate with distinct types and severity of cardiovascular diseases, including coronary heart disease, valvular disease, myocarditis, cardiomyopathy, heart failure, atherosclerosis and aneurysm, which underscores the importance of investigating macrophage regulatory mechanisms within the context of specific diseases. Besides, recent strides in single-cell sequencing technologies have revealed macrophage heterogeneity, cell–cell interactions, and downstream mechanisms of therapeutic targets at a higher resolution, which brings new perspectives into macrophage-mediated mechanisms and potential therapeutic targets in cardiovascular diseases. Remarkably, myocardial fibrosis, a prevalent characteristic in most cardiac diseases, remains a formidable clinical challenge, necessitating a profound investigation into the impact of macrophages on myocardial fibrosis within the context of cardiac diseases. In this review, we systematically summarize the diverse phenotypic and functional plasticity of macrophages in regulatory mechanisms of cardiovascular diseases and unprecedented insights introduced by single-cell sequencing technologies, with a focus on different causes and characteristics of diseases, especially the relationship between inflammation and fibrosis in cardiac diseases (myocardial infarction, pressure overload, myocarditis, dilated cardiomyopathy, diabetic cardiomyopathy and cardiac aging) and the relationship between inflammation and vascular injury in vascular diseases (atherosclerosis and aneurysm). Finally, we also highlight the preclinical/clinical macrophage targeting strategies and translational implications.

At the heart of inflammation: Unravelling cardiac resident macrophage biology

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Cardiac resident macrophages: The core of cardiac immune homeostasis

Resident macrophages as potential therapeutic targets for cardiac ageing and injury

Cardiac resident macrophages: Spatiotemporal distribution, development, physiological functions, and their translational potential on cardiac diseases

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Spatiotemporal development and the regulatory mechanisms of cardiac resident macrophages: Contribution in cardiac development and steady state

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

The role of cardiac resident macrophage in cardiac aging

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction

Inflammation Macrophages Contribute to Cardiac Homeostasis

The Characteristic of Resident Macrophages and Their Therapeutic Potential for Myocardial Infarction

New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity

Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

The Multifaceted Nature of Macrophages in Cardiovascular Disease

Transcriptomic profiling and regulatory pathways of cardiac resident macrophages in aging